COPD

By Laura Lovett November 16, 2017
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest respiratory digital health deployment with a pharmacy benefit manager yet.  The Propeller system allows a patients to attach a sensor to their inhaler, which is synced to an app on the users smart phone....
By Dave Muoio November 2, 2017
North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with a mobile app can be used to verify dose delivery in real-time. “What we’ve done is created the first electronically breath-actuated inhaler,” James Bauler, VP of business development at Pneuma...
By Dave Muoio October 31, 2017
Humana has tapped Crestwood, Kentucky-based Revon Systems for a market-wide pilot of the latter’s mobile self-triage platform, the Revon Smart Symptom Tracker. The program aims to help a select population of Medicare Advantage members with chronic obstructive pulmonary disease (COPD) better assess day-to-day variations in their symptoms. “COPD is characterized by exacerbation, and patients who...
By Jeff Lagasse September 1, 2017
Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, dubbed the SmartTouch for Symbicort.   The SmartTouch is a device that grafts onto a patient’s inhaler to monitor and encourage medication adherence as...
By Jeff Lagasse August 24, 2017
Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for, and undertake, commercial activities using the Propeller clip-on sensor and software platform for use with GSK’s ELLIPTA Inhaler.   Ongoing research and development efforts will continue, with...
By Jonah Comstock June 21, 2017
Madison, Wisconsin-based Propeller Health is now a decade old. The digital health company, which makes connected inhalers and patient- and provider-facing data analytics tools for respiratory diseases asthma and COPD, can hardly be considered a startup anymore. Nowadays the company has numerous published efficacy studies and business relationships with most major pharma companies in the...
By Heather Mack March 15, 2017
New York City-based Cohero Health, which develops connected health tools and technologies for chronic respiratory diseases, has closed on $10.5 million in Series A funding. This builds on the company’s earlier $9 million Series A round from late 2016, and the extra funding comes from new strategic investors Samsung Next and Omron Healthcare. With seed funding, this brings Cohero's total funding...
By Heather Mack February 9, 2017
A telehealth initiative at Charleston Area Medical Center led to reduced readmission rates for several chronic conditions, the health system reported today. What led to the reductions wasn’t the advent of video consultations with specialists or sophisticated biometric sensor monitoring, but health information for patients and workflow integration for hospital staff via SmarTigr, TeleHealth...
By Jonah Comstock September 20, 2016
Ochsner Health System in New Orleans has catapulted itself into the front lines of hospital innovation in the last few years as an early Apple HealthKit adopter, with its in-house "O Bar" app store, and with an initially successful blood pressure monitoring trial, the details of which Chief Clinical Transformation Officer Richard Milani shared at MobiHealthNews' event in June. At the DPharm...
By Jonah Comstock August 30, 2016
Qualcomm Life and Boehringer Ingelheim have announced that they will work together to develop the next generation of Boehringer's Respimat connected inhaler. Propeller Health, which developed the original connected inhaler for Boehringer, will continue to work with Boehringer to at least market the existing version of the device.  "The overall goal for Boehringer Ingelheim is to create health...